CELLAY INC has a total of 23 patent applications. Its first patent ever was published in 2008. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology and machines are FRESHGENE INC, LINGVITAE AS and ONCOMEDX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | United States | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Brazil | 3 | |
#5 | China | 2 | |
#6 | Australia | 1 | |
#7 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Machines |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Aurich-Costa Joan | 20 |
#2 | Ewen Elizabeth | 4 |
#3 | Gildea Michael | 4 |
#4 | Joan Aurich-Costa | 2 |
#5 | Bradley Sean P | 2 |
#6 | Moen Jr Phillip T | 1 |
#7 | Joan Aurich Costa | 1 |
#8 | Moen Phillip T Jr | 1 |
Publication | Filing date | Title |
---|---|---|
EP3066214A1 | Methods and kits for detecting a prostate carcinoma and predicting disease outcomes for prostate cancers | |
US2014120535A1 | Methods and kits for performing in situ hybridization | |
BR112014014307A2 | methods and kits for in situ detection at room temperature of a target nucleic acid in a biological sample | |
EP2576830A1 | Methods for in situ detection of nucleotide sequences | |
EP2185573A2 | Highly visible chromosome-specific probes and related methods |